{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:29:01Z","timestamp":1790314141314,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"NeoGenomics Laboratories"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.anndiagpath.2019.02.001","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T07:35:19Z","timestamp":1549784119000},"page":"105-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma"],"prefix":"10.1016","volume":"39","author":[{"given":"Dennis P.","family":"O'Malley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Fedoriw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Young","family":"Ok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2019.02.001_bb0005","series-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","year":"2017"},{"issue":"11","key":"10.1016\/j.anndiagpath.2019.02.001_bb0010","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3324\/haematol.2011.041079","article-title":"Cytotoxic molecule-positive classical Hodgkin's lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type","volume":"96","author":"Asano","year":"2011","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.anndiagpath.2019.02.001_bb0015","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/modpathol.3800473","article-title":"Rare expression of T-cell markers in classical Hodgkin's lymphoma","volume":"18","author":"Tzankov","year":"2005","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.02.001_bb0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ctrv.2010.11.005","article-title":"Rituximab in Hodgkin lymphoma: is the target always a hit?","volume":"37","author":"Saini","year":"2011","journal-title":"Cancer Treat. Rev."},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.02.001_bb0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1309\/YCH8DWUFFQBKGPVB","article-title":"The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma","volume":"120","author":"Browne","year":"2003","journal-title":"Am. J. Clin. Pathol."},{"issue":"8","key":"10.1016\/j.anndiagpath.2019.02.001_bb0030","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/modpathol.2009.54","article-title":"Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers","volume":"22","author":"Nam-Cha","year":"2009","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.anndiagpath.2019.02.001_bb0035","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000478-200312000-00003","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15","volume":"27","author":"Barry","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.anndiagpath.2019.02.001_bb0040","series-title":"Lymph nodes","author":"Weiss","year":"2008"},{"issue":"14","key":"10.1016\/j.anndiagpath.2019.02.001_bb0045","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood-2012-10-461848","article-title":"CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.02.001_bb0050","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1365-2141.2002.03456.x","article-title":"Expression pattern of MUM1\/IRF4 in the spectrum of pathology of Hodgkin's disease","volume":"117","author":"Carbone","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.02.001_bb0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jcp.55.3.162","article-title":"Hodgkin's lymphoma: the pathologist's viewpoint","volume":"55","author":"Pileri","year":"2002","journal-title":"J. Clin. Pathol."},{"issue":"12","key":"10.1016\/j.anndiagpath.2019.02.001_bb0060","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/modpathol.3800227","article-title":"Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma","volume":"17","author":"Garcia-Cosio","year":"2004","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.02.001_bb0065","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/10428190902930488","article-title":"Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis","volume":"50","author":"Slack","year":"2009","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.02.001_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1066896909331994","article-title":"The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma","volume":"18","author":"Salama","year":"2010","journal-title":"Int. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.02.001_bb0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2559.2009.03462.x","article-title":"BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma","volume":"56","author":"Hoeller","year":"2010","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.anndiagpath.2019.02.001_bb0080","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation","volume":"27","author":"Fan","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"issue":"26","key":"10.1016\/j.anndiagpath.2019.02.001_bb0085","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","article-title":"The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)","volume":"122","author":"Hartmann","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.02.001_bb0090","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/PAS.0b013e3182487158","article-title":"Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma","volume":"36","author":"Eberle","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.02.001_bb0095","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/modpathol.2010.4","article-title":"PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus","volume":"23","author":"Feldman","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.anndiagpath.2019.02.001_bb0100","article-title":"The histological, immunohistochemical and genetic features of classical Hodgkin lymphoma and anaplastic large cell lymphoma with aberrant T-cell\/B-cell antigen expression","author":"Liang","year":"2018","journal-title":"Hum. Pathol."},{"issue":"10","key":"10.1016\/j.anndiagpath.2019.02.001_bb0105","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood-2012-06-439455","article-title":"Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival","volume":"121","author":"Venkataraman","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.02.001_bb0110","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/PAS.0000000000000813","article-title":"Clinicopathological study of 30 cases of peripheral T-cell lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan","volume":"41","author":"Eladl","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.anndiagpath.2019.02.001_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41379-018-0108-5","article-title":"CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma","volume":"32","author":"Hartmann","year":"2019","journal-title":"Mod. Pathol."},{"issue":"10","key":"10.1016\/j.anndiagpath.2019.02.001_bb0120","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/00000478-199910000-00008","article-title":"Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection","volume":"23","author":"Quintanilla-Martinez","year":"1999","journal-title":"Am. J. Surg. Pathol."},{"issue":"10","key":"10.1016\/j.anndiagpath.2019.02.001_bb0125","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.5858\/arpa.2015-0197-RAI","article-title":"Reed-Sternberg-like cells in non-Hodgkin lymphomas","volume":"139","author":"Gomez-Gelvez","year":"2015","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"11","key":"10.1016\/j.anndiagpath.2019.02.001_bb0130","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/PAS.0b013e318268d9ff","article-title":"Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics","volume":"36","author":"Moroch","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.02.001_bb0135","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e3182785610","article-title":"Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin\/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist","volume":"37","author":"Nicolae","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.02.001_bb0140","first-page":"543","article-title":"Fascin, a sensitive new marker for reed-Sternberg cells of Hodgkin's disease. Evidence for a dendritic or B cell derivation?","volume":"150","author":"Pinkus","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.02.001_bb0145","doi-asserted-by":"crossref","first-page":"742","DOI":"10.5858\/2007-131-742-FEIDLB","article-title":"Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma","volume":"131","author":"Bakshi","year":"2007","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.02.001_bb0150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/00313020310001602567","article-title":"The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma","volume":"35","author":"Kim","year":"2003","journal-title":"Pathology"},{"issue":"10","key":"10.1016\/j.anndiagpath.2019.02.001_bb0155","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3324\/haematol.11523","article-title":"A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1\/IRF4","volume":"92","author":"Valsami","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2019.02.001_bb0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.humpath.2016.03.005","article-title":"Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas","volume":"54","author":"Menter","year":"2016","journal-title":"Hum. Pathol."},{"issue":"7","key":"10.1016\/j.anndiagpath.2019.02.001_bb0165","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/his.13475","article-title":"Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells","volume":"72","author":"Sakakibara","year":"2018","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.anndiagpath.2019.02.001_bb0170","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1182\/blood.V100.12.3935","article-title":"BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens","volume":"100","author":"Rassidakis","year":"2002","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.anndiagpath.2019.02.001_bb0175","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/modpathol.3800183","article-title":"Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed-Sternberg cells","volume":"17","author":"Bai","year":"2004","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.02.001_bb0180","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ajcp\/106.6.728","article-title":"P53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease","volume":"106","author":"Elenitoba-Johnson","year":"1996","journal-title":"Am. J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.02.001_bb0185","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.arcmed.2014.06.001","article-title":"Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin's lymphoma: a meta-analysis","volume":"45","author":"Lee","year":"2014","journal-title":"Arch. Med. Res."},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.02.001_bb0190","first-page":"1278","article-title":"CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome","volume":"20","author":"Rassidakis","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.anndiagpath.2019.02.001_bb0195","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/01.MP.0000032534.81894.B3","article-title":"MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas","volume":"15","author":"Copie-Bergman","year":"2002","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.02.001_bb0200","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2559.2005.02317.x","article-title":"Loss of CD19 expression in B-cell neoplasms","volume":"48","author":"Masir","year":"2006","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.02.001_bb0205","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1182\/blood.V89.3.980","article-title":"Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin","volume":"89","author":"Krenacs","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.02.001_bb0210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00000478-200103000-00003","article-title":"Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study","volume":"25","author":"Cazals-Hatem","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.anndiagpath.2019.02.001_bb0215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.anndiagpath.2016.10.003","article-title":"Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma","volume":"26","author":"Cho","year":"2017","journal-title":"Ann. Diagn. Pathol."},{"issue":"8","key":"10.1016\/j.anndiagpath.2019.02.001_bb0220","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/modpathol.3800144","article-title":"Lack of c-kit (CD117) expression in CD30+ lymphomas and lymphomatoid papulosis","volume":"17","author":"Rassidakis","year":"2004","journal-title":"Mod. Pathol."}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913419300413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913419300413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:31:06Z","timestamp":1761078666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913419300413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":44,"alternative-id":["S1092913419300413"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.02.001","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}